tm
Seeing Is Believing
tm
Seeing Is Believing
ACRS is currently covered by 7 analysts with an average price target of $13.28. This is a potential upside of $11.89 (855.4%) from yesterday's end of day stock price of $1.39.
Aclaris Therapeutics's activity chart (see below) currently has 31 price targets and 45 ratings on display. The stock rating distribution of ACRS is 68.18% BUY and 31.82% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.73% with an average time for these price targets to be met of 83.55 days.
Highest price target for ACRS is $2, Lowest price target is $1, average price target is $13.28.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Jan-2024. First documented stock forecast 02-Nov-2015.
Currently out of the existing stock ratings of ACRS, 15 are a BUY (68.18%), 7 are a HOLD (31.82%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
6 months 4 days ago
0/5 (0%)
$34.34 (396.54%)
Hold
6 months 15 days ago
0/2 (0%)
$21.59 (291.36%)
Hold
1.5
6 months 16 days ago
0/4 (0%)
$0.49 (48.51%)
Hold
1
$-0.32 (-24.24%)
2
7 months 8 days ago
1/4 (25%)
$0.06 (6.38%)
1
Hold
38
8 months 12 days ago
0/7 (0%)
$23.92 (169.89%)
What is ACRS (Aclaris Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?
Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?
Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?
